$NBY all they've done is listed these on their website? This company has sold opthamological drops, topical applications for acne. $9mm cash on hand in Sept 2019 after a $6mm offer.. Q3 2019 ER when asked, Q: "will you have new product developments coming in the near future?" A: "yes we will have new product line extensions in the near term." Q:"will it be pretty minimal operating investment, or will it be more investing in what you have right now?" (asked because they mentioned earlier their revenues into 2020 are expected to remain about the same as 2019... focusing on minimizing costs.) A: "Good question.. the name of the game right now is capitalizing on our current infrastructure to capitalize on a low cost investment... leveraging current infrastructure." Q: "Do you see your [transition into amazon-sales, with regards to Avenova] increasing over upcoming quarters?" (continued)

    Get The Stocktwits Daily Rip

    ©2020 StockTwits, Inc. All rights reserved.
    Market Data by Xignite and BATS BZX Real-Time Price

    Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC. ST Invest is a wholly owned subsidiary of StockTwits, Inc.
    Investing in securities products involves risk, including possible loss of principal.
    Please read important legal disclosures.